CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study
Authors
E. Menditto Costa, E. Midão, L. Bosnic-Anticevich, S. Novellino, E. Bialek, S. Briedis, V. Mair, A. Rajabian-Soderlund, R. Arnavielhe, S. Bedbrook, A. Czarlewski, W. Annesi-Maesano, I. Anto, J.M. Devillier, P. De Vries, G. Keil, T. Sheikh, A. Orlando, V. Larenas-Linnemann, D. Cecchi, L. De Feo, G. Illario, M. Stellato, C. Fonseca, J. Malva, J. Morais-Almeida, M. Pereira, A.M. Todo-Bom, A.M. Kvedariene, V. Valiulis, A. Bergmann, K.C. Klimek, L. Mösges, R. Pfaar, O. Zuberbier, T. Cardona, V. Mullol, J. Papadopoulos, N.G. Prokopakis, E.P. Bewick, M. Ryan, D. Roller-Wirnsberger, R.E. Tomazic, P.V. Cruz, A.A. Kuna, P. Samolinski, B. Fokkens, W.J. Reitsma, S. Bosse, I. Fontaine, J.-F. Laune, D. Haahtela, T. Toppila-Salmi, S. Bachert, C. Hellings, P.W. Melén, E. Wickman, M. Bindslev-Jensen, C. Eller, E. O&apos
Publication date
1 January 2019
Publisher
Abstract
Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12 143 users were registered. A total of 6 949 users reported at least one VAS data recording. Among them, 1 887 users reported ≥7 VAS data. About 1 195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR ≥70% and PDC ≤1.25), 51 (4.23%) were partly adherent (MPR ≥70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting. © 2018 John Wiley & Sons Lt
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3000566
Last time updated on 10/02/2023